1. Introduction
More than 120 years ago, Peter Hermann Stillmark in his doctoral thesis presented in 1888 to the University of Dorpat, gave the earliest step in the study of proteins that have a very interesting feature: the ability to agglutinate erythrocytes. These proteins were initially referred as to hemagglutinins or phytoagglutinins, since they were originally isolated from extracts of plants [1]. The first hemagglutinin isolated by Stillmark was extracted from seeds of the castor tree (
Thirty-one years after Stillmark, James B. Sumner, isolated from jack bean (
In 1907, Landsteiner and Raubitschek analyzed the hemagglutination of red blood cells from different animals by various seeds extracts. They found that the relative hemagglutinating activity was quite different for each extract tested [1]. However, it was only in the 1940s that Willian Boyd and Karl Renkonen, working independently, made the important discovery of human blood groups specificity for hemagglutinins. They found that crude extracts of two leguminous plants,
The specific interaction between lectins and carbohydrates of erythrocytes played a crucial role in the investigations of the antigens associated with the ABO blood group system. In the subsequent decade, Morgan and Watkins found that the agglutination of type A erythrocytes by extracts of
Around thirty years after Boyd, the research on lectins reached the molecular level studies. It was clear the need to a better understanding on the structural aspects of lectins. Then, in 1972 Edelman and colleagues established the primary sequence of ConA [6]. In the same year, Edelman’s group and independently Karl Hardman with Clinton Ainsworth, solved the 3D structure of ConA by X-ray crystallography [7,8].
2. What exactly is a lectin?
In 1954 Boyd and Shapleigh proposed the term lectin, from the Latin verb
Lectins were early defined as carbohydrate-binding proteins of nonimmune origin that agglutinate cells or as carbohydrate-binding proteins other than antibodies or enzymes. However, these definitions were updated, since some plant enzymes are fusion proteins composed of a carbohydrate-binding and a catalytic domain, for instance, type 2 RIPs, such as ricin and abrin, are fusion products of a catalytically active A-chain (which has the N-glycosidase activity) and a carbohydrate-binding B-chain, both linked by a disulfide bond [10]. Furthermore, there is in nature carbohydrate-binding proteins possessing only one binding site and, therefore, are not capable of precipitating glycoconjugates or agglutinating cells [11].
Thus, in 1995 Peumans and Van Damme proposed the most suitable definition for lectins. According to the “new” definition, all plant proteins that possess at least one noncatalytic domain that binds reversibly to a specific mono- or oligosaccharide are considered as lectins [12,13].
2.1. Plant lectins
Lectins are proteins widely distributed in nature such in microorganisms, plants, animals and humans, acting as mediators of a wide range of biological events that involve the crucial step of protein-carbohydrate recognition, such as cell communication, host defense, fertilization, cell development, parasitic infection, tumor metastasis, inflammation, etc [14-15].
Peumans and Van Damme classified the plant lectins according to their overall structure.
The most thoroughly investigated lectins have been isolated from plants, particularly that extracted from members of the Leguminosae family. Legume lectins are a large group of proteins that share a high degree of structural similarity with distinct carbohydrate specificities. The subtribe Diocleinae (Leguminosae) comprises 13 genera, mostly of them from the New World. However, only 3 of these genera (i.e.
Concerning the biological activity, legume lectins are considered as enigmatic proteins. Despite the philogenetic proximity as well the high degree of similarity shared between them, they possess different biological activities such as histamine release from rat peritoneal mast cells, lymphocyte proliferation and interferon-γ production, peritoneal macrophage stimulation and inflammatory reaction as well as induction of paw edema and peritoneal cell immigration in rats [16].
2.2. Plant lectins as biotechnological tools
Significant progress has been reached in last years in understanding the crucial roles of lectins in several biological processes [17]. The importance of lectins as biotechnological tools has been established early in the studies involving its biological application. In 1960 a major step in immunology was given in order to determine the role of these proteins on the lymphocytes cell division. It was found that the lectin of the red kidney bean (
In addition to immunological studies, recent works have been investigated the influence of lectins in the field of microbiology, since lectins can be considered as valuable tools to verify the role of interaction between the pathogen and carbohydrates present in host cells and its importance to disease development. For instance, it has been proposed that the pathogen
3. Carbohydrates and the neoplasic process
Currently, malignancies are considered a major problem in the public health, especially given their increasing incidence and prevalence rates observed in recent decades. In this context, the malignant tumors, or cancers, account for approximately 7.8 million deaths per year, thus becoming the second greatest cause of death worldwide, only behind the cardiovascular disease [23].
The cancer can be defined as a set of more than 100 diseases that have in common the uncontrolled growth of cells, which invade tissues and organs and can spread to other body regions [23]. Thus, both the processes of cellular mutation that affects the neoplastic cell and metastasis, involve a series of genetic changes that culminate in modifications in the pattern of several receptors and signaling molecules present on the cell surface [24].
Carbohydrates are biomolecules that have enormous potential for encoding biological information. These combined-molecules (Glycoproteins and Glycolipids) are responsible for different biological interactions between the cell and the extracellular environment [26]. Regarding the neoplastic cells, the glycosylation of these proteins and lipids is changed, which generates membrane signaling molecules capable of inducing several processes directly related to tumor progression such as cell adhesion, angiogenesis, cellular mitosis and metastasis, in addition, in some cases, be responsible for inhibition of apoptosis induction triggered by the cells of the immune system [26].
Certain changes in glycans occur frequently in neoplastic cells and may be considered "tumor-specific", establishing a correlation between the stage of disease progression and prognosis of the same [25]. Some classic examples of these changes are the antigens of the ABH and Lewis system. ABH antigens are not expressed in cells of healthy human colon but significantly expressed on tumor cells [27]. Since the antigen Lewisy can be observed in several carcinomas and has been correlated with poor prognosis in breast tumors [28]. Another example is the glycosylated antigens sialyl-LewisA and sialyl-Lewisx, which are significantly up-regulated in carcinomas of the colon and appear to be related to tumor progression [29].
Thus, due to the intrinsic role of carbohydrates in the tumorigenesis, the glycosylation process as well as the identification of glycosylated antigens have been intensively focused, given the fact that glycosylation of antigens can vary extensively depending on the stage of the disease, which can provide, when properly identified, a better possibility of correct diagnosis and treatment.
4. Application of plant lectins in the diagnosis of malignant tumors
Because the peculiar characteristic of specific binding to carbohydrates, lectins have been used as tools to identify aberrant glycans expressed by neoplastic cells. Such methods have been essential to obtain a more precise diagnosis that allows a more accurate prognosis.
Several methods regarding the use of lectins as tools for recognizing aberrant glycans have been proposed in recent days [30,31,32]. The technique most common and widespread is the use of lectins in immunohistochemical assays.
In this context, the study conducted by [30], showed that leguminous lectins from
Another recent methodology was addressed by [33]. This methodology exploits the fact that glycoproteins produced by cancer cells have altered glycan structures, although the proteins themselves are common, ubiquitous, abundant, and familiar. However, as cancer tissue at the early stage probably constitutes less than 1% of the normal tissue in the relevant organ, only 1% of the relevant glycoproteins in the serum should have altered glycan structures [34]. With that in mind, the strategy to approach the detection of these low-level glycoproteins is based in: (a) a quantitative real-time PCR array for glycogenes to predict the glycan structures of secreted glycoproteins; (b) analysis by lectin microarray to select lectins that distinguish cancer-related glycan structures on secreted glycoproteins; and (c) an isotope-coded glycosylation site-specific tagging high-throughput method to identify carrier proteins with the specific lectin epitope [33].
Therefore, further analyses of lectins as biomarkers have been undertaken to improve our understanding of the processes involved in malignant tumor formation. As well as enable us to acquire new methods of identification of neoplastic cells at an early stage, enabling a better prognosis with appropriate treatment and low cost.
5. Application of plant lectins in the treatment of malignant tumors
Apoptosis is a mechanism by which cells undergo death to control cell proliferation or in response to irreparable DNA damage. It is featured by unique morphological and biochemical changes, such as nucleus condensation and margination, membrane blebbing, and inter-nucleosomal DNA cleavage [35]. As the type I programmed cell death (PCD), apoptosis occurs through two major pathways, the extrinsic pathway triggered by the Fas death receptors, and the mitochondria-dependent pathway that brings about the release of Cytocrome
Several studies have demonstrated that lectins can induce apoptotic cell death. In the mitochondrial-dependent pathway, ConA treatment results in a decrease of mitochondrial membrane potential, and thus collapsing mitochondrial transmembrane potential. Cyto
In [38], it was evaluated the pro-apoptotic activity of a lectin isolated from
An interesting study conducted by [39] showed the pro-apoptotic caspase-dependent activity of the lectin isolated from
Despite the apoptotic activity of several lectins have been demonstrated in different studies, the precise mechanism of how this process is triggered as well the mode of internalization is unknown until the present date.
6. Carbohydrates and the inflammatory process
The inflammation is a nonspecific event of immune response that occurs in reaction to any type of tissue injury. This process is capable of triggering a series of physiological changes such as increased blood flow, elevated cellular metabolism, vasodilation, release of soluble mediators, extravasation of fluids and cellular influx [41].
The continuity of cell recruitment and tissue damage in addition to chemical mediators released by the injured tissue as well as resident cells on site activate various mechanisms, in turn, induce the migration of more immune cells as well as increasing local tissue perfusion [42].
Both, acute and chronic inflammations have specific characteristics and the innate immune system plays a central role, since it mediates the initial response. Infiltration of innate immune cells, specifically neutrophils and macrophages, characterizes the acute inflammation, while infiltration of T lymphocytes and plasma cells are features of chronic inflammation [41,42].
As discussed previously, carbohydrates can act as the intermediates of communication in biological processes such as differentiation, proliferation and certain cell–cell interactions that are crucially important in both physiological and pathological phenomena [43,44]. The information contained in the enormous variety of oligosaccharide structures normally conjugated to proteins or lipids on cell surfaces (glycocodes) is recognized and deciphered by a specialized group of structurally diverse proteins, the lectins [44].
Galectins (formerly “S-type lectins”), an evolutionarily conserved family of endogenous animal lectins, share unique features, including their highly conserved structure, exquisite carbohydrate specificity, and ability to differentially regulate a myriad of biological responses [45].
Although galectins have been implicated in many biological activities, most of the functional studies reported to date link galectins to early developmental processes, such as neovascularization, regulation of immune cell homeostasis and inflammation [44,46,47]. Through deciphering glycan-containing information about host immune cells or microbial structures, galectins can modulate a diversity of signaling events that lead to cellular proliferation, survival, chemotaxis, trafficking, cytokine secretion and cell−cell communication [46,47].
These findings are extremely important because they demonstrate the importance of the glicocodes in the process of cell recognition and inflammation. In this context, plant lectins have been widely used to understand the pro-inflammatory mechanisms, as well as the design of new compounds with pro-healing effect.
7. Plant lectins and its immunomodulatory activity
An immune system is a system of biological structures and processes within an organism that protects against disease. In order to function properly, an immune system must detect a wide variety of agents, from viruses to cancer cells, and distinguish them from the organism's own healthy tissue [41]. The immune system is composed of many cells and molecules that act in a complex and harmonious way with the ultimate goal of annihilating the aggressive factor [42].
In the immune system, two phases of activity can be clearly established: the innate immune response and the adaptive immune response. In the innate immune response, there is the activity of cells and cytokines in a nonspecific way with the main purpose to annihilate quickly the local damaging agents. At this stage, we highlight the neutrophils, eosinophils, basophils and macrophages, cells with well-established activities but with the common function of production and release of cytokines. These cytokines are molecules with various functions in the inflammatory process, such as chemotaxis, activation of certain cell groups and increased tissue perfusion [48].
On the other hand, the adaptive immune response is composed by another set of cells that acts in a more specific way, the lymphocytes. Such cells are responsible for producing antibodies specific for certain invading microorganisms and the activation of mechanisms of apoptosis in abnormal cells [49].
Thus, the use of molecules capable of inducing cell recruitment as well as cytokine production and lymphocytes proliferation is of special scientific interest.
Korean mistletoe (
A recent study [51] demonstrated the immunomodulatory activity of ConBr, a lectin isolated from
Regarding the activity of lectins on lymphocytes, a recent study [52] evaluated the effect of lectin extracted from seeds of
The biological function of carbohydrates in inflammation events is well-defined. In this context, proteins that bind specifically to such glycans are of great interest because of their possible functions and applications in biotechnological studies.
8. Plant lectins and its pro-healing activity
Recently, researches have undertaken efforts at the possible pro-healing activity of some lectins [53,54]. This goal is supported by the fact that such molecules may interfere with the inflammatory process. This effect is not yet fully elucidated, however peculiar and interesting results can be observed.
Experiment conducted in a murine model, employing the lectin isolated from
Although promising, this issue requires further studies to better characterize the mechanisms involved in pro-healing role played by lectins.
9. Marine algae lectins
To date, there are fewer than 100 publications describing the presence of lectins in marine red, green and brown macroalgae. Moreover, and in marked contrast to higher land plant lectins, marine algal lectins have been isolated and characterized at a much lower pace since the first report of haemagglutinating activity in these organisms appeared more than 46 years ago [56]. Thereafter, other studies describing the presence and/or purification of algal lectins were reported by groups from England [57], Japan [58], Spain [59], United States [60] and Brazil [61].
Currently, the presence of lectins was analyzed at about 800 algae species. However, this number is still small, considering that there are thousands of species of marine algae. Together, the research shows that approximately 60% of the analyzed species show hemagglutinating activity. The number of positive species could be higher since in the first screenings the authors used a limited number of red blood cells and without enzyme treated erythrocytes.
The improvement in the methodologies of both, extraction and hemagglutination assays could increase the number of positive species. In fact, there appears to be coincidence that the rabbit erythrocytes treated with papain are most suited for the hemagglutinating activity detection in marine macroalgae [62,63].
Although marine algal lectins show proteinaceous content similar to lectins from terrestrial plants, they differ in some aspects. Early publications on this issue, reported that in general, lectins from algae have low molecular masses, no affinity for monosaccharides, strong specificity for complex oligosaccharides and/or glycoproteins. Moreover, they appear to have no requirement for metal ions, showing high content of acidic residues and even in high concentrations tend to stay in the monomeric form [64,65,66]. However there are a few reports showing that some of these molecules may be inhibited by simple sugars and are cation dependent as showed for the lectins from the green marine alga genus,
The classical methods used to purify marine algae lectins include methods such as protein precipitation (using salt or ethanol), liquid chromatography (especially affinity) and electrophoresis [69,71]. Ion exchange chromatography has been effectively used in the isolation of lectins from seaweed, mainly in initial stages in purification. In this step, the lectins were separated from pigments present in the extracts [66,72,73]. In the protein extracts, phycobilins are co-extracted with lectins, becoming an undesirable contaminant in the purification process [72].
Lectins from marine algae
To date, only 31 lectins from Rhodophyceae and 17 lectins from Chlorophyceae were isolated and characterized. The virtual absence of lectins isolated from brown algae (Phaeophyta) is mainly due to the amount of polyphenols present in plants. It is known that polyphenols are released in extraction and that these compounds and their oxidation products, quinones, bind tightly to proteins [94] causing a false hemagglutination [83,95].
Even with the increase in the publications related to marine algae lectins, biochemical and structural information on algal lectins is scarce and from only a few species, and hence the functional and phylogenetic classification of these lectins remains unclear. The available structural information indicates the existence of different carbohydrate-binding proteins in the marine algae investigated. Moreover, the complete amino acid sequences of only 14 algal lectins have been determined. In red marine algae,
In same year, [97] reported the primary structure of
On the other hand, the lectins isolated from
Recently [90] reported that the aggregation of cell organelles of
The lectin BPL-2 is a 17 kDa protein specific to D-mannose (ref). The authors found no similarity with others proteins in specific databases. The BPL-3 [92] possesses specificity to
Another observation is that a large number of sequenced algal lectins have the presence of cysteinyl residues or the duplication of internal domain. Still a lot of work needs to be done on the structure of algal lectins, since a few amount of primary structures has been determined. Further structural studies will contribute to understanding the differences in their biochemical characteristics as well as to the evolutionary aspects upon lectin presence in land plants and marine algae.
10. Marine algae lectins and its biotechnological role
There are few studies in the literature about the biotechnological applicability of lectins from marine algae. Probably due to low rentability of lectins obtained through the purification processes. It is noteworthy that the majority of lectins isolated so far were extracted from red algae, which are rich in carbohydrates and not in proteins. Moreover, during the extraction of algae proteins, phycobiliproteins are extracted simultaneously, and therefore the addition of steps to remove these phycobiliproteins causes losses of other proteins, among these are the lectins.
However, several studies on biological applications of algae lectins demonstrate that these molecules have an additional benefit; they are molecules with low molecular weight and may be less antigenic when used in biological models.
In cancerology, it was demonstrated that a lectin from the red marine algal
In current studies, Span 80 vesicles (a potential type of nonionic vesicular drug delivery system) with ESA and PEGylated (EPV) lipids immobilized, showed hemagluttinating activity similar to free ESA and decreased the viability of Colo201 cancer cells
The lectins isolated from the red marine algae
Concerning the mitogenic activity, the lectin from the red marine alga
The antibacterial effect was too evaluated. The lectins from the red marine algal
Red marine algae lectins from
Concerning the antiviral effects, a lectin named KAA-2 from the red marine algal
11. Lectins as biotechnological tools to study the microbial biofilms
Biofilms are microbial complex communities established in a wide variety of surfaces and are generally associated with an extracellular matrix composed by several types of polymers [121]. This type of microbial association can develop on biotic and abiotic surfaces, including living tissues, medical devices and/or industrial water piping systems and marine environments [122,123,124].
Bacterial infections involving biofilm formation are usually chronic and often present a arduous treatment [125,126,127]. The growth and proliferation of microorganisms inside the biofilm provides reduction or prevents the penetration of various antimicrobial agents [128,129] and thus become extremely difficult or impossible to eradicate them [130,131,132]. For some antibiotics, the concentration required to eliminate the biofilm can be up to a thousand times higher than required to planktonic form of the same specie [127].
The ability of microorganisms to form pathogenic cell aggregates is a worldwide concern. In attempt to remedy this problem, pharmaceutical companies associated to research groups work avidly to the development of new options for the treatment of infections caused by bacteria organized in biofilms.
Biofilm formation is a process in which bacteria has a change in lifestyle, it goes from a state unicellular in suspension to a multicellular sessile, where the growth and cell differentiation results in structured communities. The biofilm begins with the setting free of microorganisms in a given area. The first microorganisms adhere initially by weak interactions, mainly of the van der Waals forces [133]. If the colonies are not immediately removed from the surface, they can anchor by cell adhesion molecules existing in the pili and / or flagella [134]. The first colonies facilitate the arrival of other cells through adhesion sites and begin to build the matrix that will form the biofilm. Only a few species are able to adhere to a surface
According to [136], the biofilm development occurs through three events. At first, there is a distribution of fixed cells in surface through cell motility. Then, occurs the proliferation of fixed cells by division, expanding to upward and sides forming agglomerated of cells, similar to the formation of colonies on agar plates [137]. Finally, clusters of cells attached to the biofilm are recruited by the action of the environment itself to the development of other biofilms, reaching a climax community [136]. These general stages provide guidance to the study of biofilms by bacteria furniture, although many details of regulation of this process may vary between species.
One of the biofilm-forming components of great importance in the maintenance of cell clusters is the matrix polymeric called EPS (
The first step to biofilm formation, the early adhesion, is considered essential for colonization and infection by pathogenic bacteria. Macromolecules surfaces are directly involved in this stage [142]. Proteins known as adhesins are able to recognize specific polysaccharide substrate present on the surface to be colonized, for example, the presence of carbohydrates existing in the film of saliva that covers the teeth in the oral environment [143]. Glycidic epitopes present on surfaces of microorganisms (early colonizers) can also be recognized by these proteins to mediate an event known as coaggregation, which will start the formation of a multi-species community [144].
One etiological factor for the development of teeth biofilms is the adhesion of pathogenic bacteria in the dental enamel [145]. However, the microorganisms are not deposited directly on the tooth surface, but bind to a thin acellular layer composed of salivary proteins and other macromolecules that cover the tooth surfaces called acquired pellicle [146,147].
The acquired pellicle is formed by glycoproteins and carbohydrates that serve as receptors for bacteria containing proteins with glucan-binding domains [148]. Bacteria interact with the film by several specific mechanisms, including the interaction lectin-like involving the bacterial adhesins and receptors existing in the pellicle [148,149]. Next, other bacteria can adhere to the film as well as the bacteria pre-existing in the biofilm [150].
The event coaggregation is a phenomenon widely observed in diverse microbial communities [151,152,153]. Cells can interact in suspension, forming cell aggregates, as well as connect directly on biofilm in the process of formation. In the first case, plancktonic cells recognize specifically species genetically distinct creating the coaggregates. In other situations, coaggregates in the form of secondary colonizers can adhere on biofilm in development, a process known as coadhesion. Both cases have an important role in the integration and establishment of a mature biofilm [154].
Thus, carbohydrate residues have an important role in formation and maintainability of microbial biofilms. They act as mediators of the binding between bacteria and the surface that will serve as substrate for biofilm formation [155], as well as site of interaction between microorganisms to form cell aggregates [156,157]. Furthermore, through EPS matrix, maintains the biofilm attached in the surface, conferring a greater resistance to antimicrobial agents in general [158,159].
Molecules able to bind specifically and selectively to carbohydrates have a key importance in the development of research related to microbial biofilms. Thus, lectins have been shown as powerful tools for analyze the glycidic structures of those aggregates from microbial origin [160,161].
Studies of microbial biofilms through the interaction with lectins have two main objectives: visualization and characterization of polymeric matrix (EPS) formed by different species of microorganisms [162,163] and inhibition of oral biofilm formation by blocking the bacterial binding sites present in the pellicle of saliva in the form of glycoproteins and / or carbohydrates [164].
The application of lectins in the characterization of EPS is already widely exploited by many research groups. Lectin of wheat germ (WGA) was used as a marker of
In 1980s was developed a system called ELLA (
Recent studies demonstrated the characteristics and distribution of glycoconjugates in cyanobacteria biofilm using lectins with different specificities. In this study the authors stated that the distribution of carbohydrates in the matrix is very variable. Based on lectin specificity, glycoconjugates produced by cyanobacteria biofilm contained mainly fucose, N-acetyl-glucosamine or -galactosamine and sialic acid [169].
Lectins may be a suitable antiadhesion agent for
Acknowledgement
We would like to thank CNPq, CAPES, FUNCAP and UFC for financial support. AHS, BSC, CSN, EHT, KSN are senior investigators of CNPq.
References
- 1.
Sharon N. Lis H. 2004 History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology. 14:53R EOF 62R EOF - 2.
Franz H. 1988 The ricin story. Adv Lectin Res.1 10 25 - 3.
Olsnes S. 2004 The history of ricin, abrin and related toxins. Toxicon.44 361 70 - 4.
Sumner JB, Howell SF 1936 The identification of the hemagglutinin of the jack bean with concanavalin A. J Bacteriol.32 227 237 - 5.
Boyd W. C. Shapleigh E. 1954 Specific precipitation activity of plant agglutinins (lectins). Science. 119: 419. - 6.
Morgan WT, Watkins WM 2000 Unraveling the biochemical basis of blood group ABO and Lewis antigenic specificity. Glycoconj J.17 501 530 - 7.
Edelman GM, Cunningham BA, Reeke GN, Becker JW, Waxdal MJ, Wang JL 1972 The covalent and threedimensional structure of concanavalin A. Proc Natl Acad Sci USA.69 2580 2584 - 8.
Hardman KD, Ainsworth CF 1972 Structure of concanavalin A at 2.4-A° resolution. Biochemistry.11 4910 4919 - 9.
Hou F. J. Xu H. Liu W. Y. 2003 Simultaneous existence of cinnamomin (a type II RIP) and small amount of its free A- and B-chain in mature seeds of camphor tree. Int J Biochem Cell Biol.35 455 64 - 10.
Van Damme E. J. M. Balzarini J. Smeets K. Van Leuven F. Peuinans W. J. 1994 The monomeric and dimeric mannose binding proteins from the Orchidaceae species Listeru ovata and Epipactis helleborine: sequence homologies and differences in biological activities. Glycoconjugate J.11 321 332 - 11.
Peumans WJ, Van Damme EJ 1995 Lectins as plant defense proteins. Plant Physiol.109 347 52 - 12.
Van Damme E. J. Peumans W. J. Barre A. Rougé P. 1998 Plant lectins: a composite of several distinct families of structurally and evolutionary related proteins with diverse biological roles. Crit Rev Plant Sci.17 645 662 - 13.
Sharon N. Lis H. 1989 Lectins as cell recognition molecules. Science.246 227 234 - 14.
Sharon N. 2007 Carbohydrate-specific reagents and biological recognition molecules. J Biol Chem.282 2753 2764 - 15.
BS Cavada Barbosa. T. Arruda S. Grangeiro T. B. Barral-Netto M. 2001 Revisiting proteus: do minor changes in lectin structure matter in biological activity? Lessons from and potential biotechnological uses of the Diocleinae subtribe lectins. Curr Protein Pept Sci.2 123 135 - 16.
Wu A. M. Lisowska E. Duk M. Yang Z. 2009 Lectins as tools in glycoconjugate research. Glycoconj J.26 899 913 - 17.
Nowell PC 1960 Phytohemagglutinin: an initiator of mitosis in culture of animal and human leukocytes. Cancer Res.20 462 466 - 18.
de Oliveira Silva. F. das Neves. Santos P. de Melo C. M. Teixeira E. H. de Sousa Cavada. B. Arruda F. V. Cajazeiras J. B. Almeida A. C. Pereira V. A. Porto A. L. 2011 Immunostimulatory activity of ConBr: a focus on splenocyte proliferation and proliferative cytokine secretion. Cell Tissue Res.346 237 44 - 19.
Biol Pharm BullLee J. Y. Kim J. Y. Lee Y. G. Byeon S. E. Kim B. H. Rhee M. H. Lee A. Kwon M. Hong S. Cho J. Y. (200 In vitro. immunoregulatory effects. of Korean. Mistletoe lectin. on functional. activation of. monocytic macrophage-like cells. 30 2043 2051 - 20.
Melo C. M. L. BA Paim Zecchin. K. G. Morari J. Chiarrati M. R. Correia M. T. S. Coelho L. C. B. B. Paiva P. M. G. 2010 Cramoll 1,4 lectin increases ROS production, calcium levels and cytokine expression in treated spleen cells of rats. Mol Cell Biochem.342 163 169 - 21.
Ringnér M. Valkonen K. H. Wadström T. 1994 Binding of vitronectin and plasminogen to Helicobacter pylori. FEMS Immunol Med Microbiol.9 29 34 - 22.
Bennett HJ, Roberts IS 2005 Identification of a new sialic acid-binding protein in Helicobacter pylori. FEMS Immunol Med Microbiol.44 163 9 - 23.
Curado M. Edwards B. Shin H. Storm H. H. Ferlay J. Heanue M. Boyle P. 2008 Cancer incidence in five continents. Lyon: International Agency for Research on Cancer. 837 p. - 24.
Saeland E. van Kooyk Y. 2011 Highly glycosylated tumour antigens: interactions with the immune system. Biochem Soc Trans.39 388 92 - 25.
Nangia-Makker P. Conklin J. Hogan V. Raz A. 2002 Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med.8 187 92 - 26.
Taniguchi N. Korekane H. 2011 Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. BMB Rep.44 772 81 - 27.
Cooper HS, Haesler WE Jr 1978 Blood group substances as tumor antigens in the distal colon. Am J Clin Pathol.69 594 8 - 28.
Madjd Z. Parsons T. Watson N. F. Spendlove I. Ellis I. Durrant L. G. 2005 High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res.7 80 7 - 29.
St Hill. CA Farooqui M. Mitcheltree G. Gulbahce H. E. Jessurun J. Cao Q. Walcheck B. 2009 The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1 6 N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer. 9: 79. - 30.
Sobral AP, Rego MJ, Cavalacanti CL, Carvalho LB Jr, Beltrão EI 2010 ConA and UEA-I lectin histochemistry of parotid gland mucoepidermoid carcinoma. J Oral Sci.52 49 54 - 31.
J Biomed Biotechnol. 2010: 179817de Lima A. L. Cavalcanti C. C. Silva M. C. Paiva P. M. Coelho L. C. Beltrão E. I. dos S. Correia M. T. (201 Histochemical evaluation. of human. prostatic tissues. with Cratylia. mollis seed. lectin - 32.
Beltrão E. I. Medeiros P. L. Rodrigues O. G. Figueredo-Silva J. MM Valença Coelho. L. C. Carvalho L. B. Jr 2003 Parkia pendula lectin as histochemistry marker for meningothelial tumour. Eur J Histochem.47 139 42 - 33.
Narimatsu H. Sawaki H. Kuno A. Kaji H. Ito H. Ikehara Y. 2010 A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J.277 95 105 - 34.
Rüegg C. 2006 Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J Leukoc Biol.80 682 684 - 35.
Ghobrial IM, Witzig TE, Adjei AA 2005 Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.55 178 94 - 36.
Michael OH 2000 The biochemistry of apoptosis. Nature.407 770 7 - 37.
Li C. Y. Xu H. L. Liu B. Bao J. K. 2010 Concanavalin A, from an old protein to novel candidate anti-neoplastic drug. Curr Mol Pharmacol.3 123 8 - 38.
JA, Domingues L (Oliveira C. Nicolau A. Teixeira J. A. Domingues L. (201 Cytotoxic effects. of native. recombinant frutalin. a. plant galactose-binding. lectin on. He La cervical. cancer cells. 2011 Cytotoxic effects of native and recombinant frutalin, a plant galactose-binding lectin, on HeLa cervical cancer cells. J Biomed Biotechnol. 2011:568932 EOF 9 EOF - 39.
Huang L. H. Yan Q. J. Kopparapu N. K. Jiang Z. Q. Sun Y. 2011 Astragalus membranaceus lectin (AML) induces caspase-dependent apoptosis in human leukemia cells. Cell Prolif.45 15 21 - 40.
Lavrik I. N. Golks A. Krammer P. H. 2005 Caspases pharmacological manipulation. J Clin Invest.115 2665 72 - 41.
Ferrero-Miliani L. Nielsen O. H. Andersen P. S. Girardin S. E. 2007 Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol.147 227 35 - 42.
Margetic S. 2012 Inflammation and haemostasis. Biochem Med (Zagreb).22 49 62 - 43.
Hurwitz Z. M. Ignotz R. Lalikos J. F. Galili U. 2012 Accelerated porcine wound healing after treatment with α-gal nanoparticles. Plast Reconstr Surg. 129: 242e-251e. - 44.
Di Lella S. Sundblad V. Cerliani J. P. Guardia C. M. Estrin D. A. Vasta G. R. Rabinovich G. A. 2011 When galectins recognize glycans: from biochemistry to physiology and back again. Biochemistry.50 7842 57 - 45.
Rabinovich G. A. Toscano M. Jackson D. A. Vasta G. 2007 Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol. 17: 513−520. - 46.
Rabinovich GA, Ilarregui JM 2009 Conveying glycan information into T-cell homeostatic programs: A challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol Rev. 230: 144−159. - 47.
Rabinovich G. A. Toscano M. 2009 Turning “sweet” on immunity: Galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol. 9: 338−352. - 48.
Rodríguez R. M. López-Vázquez A. López-Larrea C. 2012 Immune systems evolution. Adv Exp Med Biol.739 237 51 - 49.
Fiocchi C. 2011 Early versus late immune mediated inflammatory diseases. Acta Gastroenterol Belg.74 548 52 - 50.
Biol Pharm Bull.Lee J. Y. Kim J. Y. Lee Y. G. Byeon S. E. Kim B. H. Rhee M. H. Lee A. Kwon M. Hong S. Cho J. Y. (200 In vitro. immunoregulatory effects. of Korean. mistletoe lectin. on functional. activation of. monocytic macrophage-like cells. 30 2043 51 - 51.
de Oliveira Silva. F. das Neves. Santos P. de Melo C. M. Teixeira E. H. de Sousa Cavada. B. Arruda F. V. Cajazeiras J. B. Almeida A. C. Pereira V. A. Porto A. L. 2011 Immunostimulatory activity of ConBr: a focus on splenocyte proliferation and proliferative cytokine secretion. Cell Tissue Res.346 237 44 - 52.
de Melo CM, de Castro MC, de Oliveira AP, Gomes FO, Pereira VR, Correia MT, Coelho LC, Paiva PM 2010 Immunomodulatory response of Cramoll 1,4 lectin on experimental lymphocytes. Phytother Res.24 1631 6 - 53.
Brustein VP, Souza-Araújo FV, Vaz AF, Araújo RV, Paiva PM, Coelho LC, Carneiro-Leão AM, Teixeira JA, Carneiro-da-Cunha MG, Correia MT 2012 A novel antimicrobial lectin from Eugenia malaccensis that stimulates cutaneous healing in mice model. Inflammopharmacology. 20. - 54.
Neto L. G. Pinto Lda. S. Bastos R. M. Evaristo F. F. MA Vasconcelos Carneiro. V. A. Arruda F. V. Porto A. L. Leal R. B. Júnior V. A. BS Cavada Teixeira. E. H. 2011 Effect of the lectin of Bauhinia variegata and its recombinant isoform on surgically induced skin wounds in a murine model. Molecules.16 9298 315 - 55.
Li B. Wang J. H. 2011 Fibroblasts and myofibroblasts in wound healing: force generation and measurement. J Tissue Viability.20 108 20 - 56.
Boyd WC, Almodovar LR, Boyd LG 1966 Agglutinins in marine algae for human erythrocytes. Transfusion6 82 83 - 57.
Blunden G. Rogers D. J. Farnham W. F. 1975 Survey of British seaweeds for hemagglutinins. Lloydia38 162 168 - 58.
Kamiya H. Ogata K. Hori K. 1982 Isolation and characterization of a new lectin in the red alga Palmaria palmata (L.) O. Kuntze. Bot Marina.15 537 540 - 59.
Fabregas J. Munoz A. Llovo J. Abalde J. 1984 Agglutinins in marine red algae. IRCS Medical Science12 298 299 - 60.
Chiles TC, Bird KT 1989 A comparative study of animal erythrocyte agglutinins from marine algae. Comp Biochem Physiol94 107 111 - 61.
Ainouz IL, Sampaio AH 1991 Screening of Brazilian marine algae for hemaglutinins. Bot Marina34 211 214 - 62.
Phytochemistry.Hori K. Ikegami S. Miyazawa K. Ito K. (198 Mitogenic antineoplastic isoagglutinins. from red. alga Solieria. robusta 27 2063 2067 - 63.
Ainouz I. L. Sampaio A. H. Benevides N. M. B. Freitas A. L. P. Costa F. H. F. Carvalho M. R. Pinheiro-Joventino F. 1992 Agglutination of enzyme treated erythrocytes by Brazilian marine algal extracts. Bot Marina35 475 479 - 64.
Rogers D. J. Hori K. 1993 Marine algal lectins: new developments. Hydrobiologia, 260/261 589 593 - 65.
Hori K. Miyazawa K. Ito K. 1990 Some common properties of lectins from marine algae. Hydrobiologia.205 561 566 - 66.
Ainouz I. L. Sampaio A. H. Freitas A. L. P. Benevides N. M. B. Mapurunga S. 1995 Comparative study on hemagglutinins from the red marine algae Bryothamnion triquetrum and B. Seaforthii. Rev Bras Fisiol Vegetal.7 15 19 - 67.
Rogers D. J. Swain L. Carpenter B. G. Critchley A. T. 1994 Binding of N-acetyl-D-galactosamine by lectins from species of green marine alga genus, Codium. Clin Biochem.10 162 165 - 68.
Sampaio AH, Rogers DJ, Barwell CJ 1998 A galactose specific lectin from the red marine alga Ptilota filicina. Phytochemistry48 765 769 - 69.
Sampaio A. H. Rogers D. J. Barwell C. J. Saker-Sampaio S. Costa F. H. F. Ramos M. V. 1999 A new isolation and further characterization of the lectin from the red marine alga Ptilota serrata. J Appl Phycol10 539 546 - 70.
Sampaio A. H. Rogers D. J. Barwell C. J. Saker-Sampaio S. Nascimento K. S. Nagano C. S. Farias W. R. L. 2002 New affinity procedure for the isolation and further characterization of the blood group B specific lectin from the red marine alga Ptilota plumosa. J Appl Phycol.14 489 496 - 71.
Sharon N. Lis H. 1990 Legume lectins- a large family of homologous proteins. FASEB J.4 3198 3208 - 72.
Rogers D. J. Fish B. Barwell C. J. Loveless R. W. 1988 Lectins from marine algae associated with photosynthetic accessory proteins. In.INTERNATIONAL LECTIN MEETING, Berlin/New York. Proceedings of the 9th Lectin Meeting. Berlin/New York: Walter de Gruyter.6 373 376 - 73.
Costa FHF, Sampaio AH, Neves SA, Rocha MLA, Benevides NMB, Freitas ALP 1999 Purification and partial characterization of a lectin from the red marine alga Amansia multifida. Physiol Mol Biol Plants.5 53 61 - 74.
Kamiya H. Shiomi K. Shimizu Y. 1980 Marine biopolymers with cell specificity III agglutinins in the red alga Cystoclonium purpureum: isolation and characterization. J Natur Products.43 136 139 - 75.
Shiomi K. Yamanaka H. Kikuchi T. 1981 Purification and physicochemical properties of a hemagglutinin (GVA-1) in the red alga Gracilaria verrucosa. Bull Jap Soc Sci Fisheries.47 1079 1084 - 76.
Kamiya H. Ogata K. Hori K. 1982 lsolation and characterization of a: new agglutinin in the red alga Palmaria palmata (L.) O. Kuntze. Bot Marina.25 537 540 - 77.
Benevides NMB, Leite AM, Freitas ALP 1996 Atividade hemaglutinante na alga vermelha Solieria filiformis. R Bras Fisiol Vegetal8 117 122 - 78.
Benevides NMB, Holanda ML, Melo FR, Freitas ALP, Sampaio AH 1998 Purification and partial characterization of the lectin from the red marine alga Enantiocladia duperreyi (C. Agardh) Faalkenberg. Bot Marina41 521 525 - 79.
Nagano C. S. Moreno F. B. Bloch Jr C. Prates M. V. Calvete J. J. Saker-Sampaio S. Farias W. R. Tavares T. D. Nascimento K. S. Grangeiro T. B. BS Cavada Sampaio. A. H. 2002 Purification and characterization of a new lectin from the red marine alga Hypnea musciformis. Protein Pept Lett.9 159 66 - 80.
Leite YFMM, Silva LMCM, Amorim RCN, Freire EA, Jorge DMM, Grangeiro TB, Benevides NMB 2005 Purification of a lectin from the marine red alga Gracilaria ornata and its effect on the development of the cowpea weevil Callosobruchus maculatus (Coleoptera: Bruchidae). Bioch et Bioph Acta.1724 137 145 - 81.
Nascimento K. S. Nagano C. S. Nunes E. V. Rodrigues R. F. Goersch G. V. BS Cavada Calvete. J. J. Saker-Sampaio S. Farias W. R. L. Sampaio A. H. 2006 Isolation and characterization of a new agglutinin from the red marine alga Hypnea cervicornis J. Agardh. Biochem Cel Biol.84 49 54 - 82.
Souza B. W. S. Andrade F. K. Teixeira D. I. A. Mansilla A. Freitas A. L. P. 2010 Haemagglutinin of the antarctic seaweed Georgiella confluens (Reinsch) Kylin: isolation and partial characterization. Polar Biol.1 1 8 - 83.
Rogers D. J. Loveless R. W. Balding P. 1986 Isolation and characterization of the lectins from sub-species of Codium fragile. In. INTERNATIONAL LECTIN MEETING, Berlin/New York. Proceedings of the 7th Lectin Meeting. Berlin/New York: Walter de Gruyter.5 155 160 - 84.
Fabregas J. Muñoz A. Llovo J. Carracedo A. 1988 Purification and partial purification of tomentine. An N-acetylglucosamine-specific lectin from green alga Codium tomentosum (huds) Stackh. J Exp Mar Biol Ecology.124 21 30 - 85.
Rogers D. J. Flangu H. 1991 Lectins from Codium species. Br Phycol J.26 95 96 - 86.
Sampaio AH, Rogers DJ, Barwell CJ 1998 Isolation and characterization of the lectin from the green marine alga Ulva lactuca. Bot Marina41 765 769 - 87.
Benevides NMB, Holanda ML, Melo FR, Pereira MG, Monteiro ACO, Freitas ALP 2001 Purification and partial characterization of the lectin from the marine green alga Caulerpa cupressoides (Vahl) C. Agardh. Bot Marina44 17 22 - 88.
Ambrosio A. Sanz L. Sanchez E. I. Wolfenstein-Todel C. Calvete J. J. 2003 Isolation of two novel mannan- and L-fucose-binding lectins from the green alga Enteromorpha prolifera: biochemical characterization of EPL-2. Archives of Biochemistry and Biophysics415 245 250 - 89.
Wang S. Zhong F. D. Zhang Y. J. Wu Z. J. Lin Q. Y. Xie L. H. 2004 Molecular characterization of a new lectin from the marine alga Ulva pertusa. Acta Biochim Biophys Sin.36 111 117 - 90.
Kim GH, Klochkova TA 2005 Purification and Characterization of a Lectin, Bryohealin, Involved in the Protoplast Formation of a Marine Green Alga Bryopsis Plumosa (Chlorophyta). J Phycol.42 86 95 - 91.
Han JW, Jung MG, Kim MJ, Yoon KS, Lee KP, Kim GH 2010 Purification and characterization of a D-mannose specific lectin from the green marine alga, Bryopsis plumose. Phycol Res.58 143 150 - 92.
Han JW, Yoon KS; Klochkova TA, Hwang M-S, Kim GH 2011 Purification and characterization of a lectin, BPL-3, from the marine green alga Bryopsis plumosa. J Appl Phycol.23 745 753 - 93.
Niu J. Wang G. Lü F. Zhou B. Peng G. 2009 Characterization of a new lectin involved in the protoplast regeneration of Bryopsis hypnoides. Chin J Oceanol Limnol.27 502 512 - 94.
Loomis WD 1974 Overcoming problems of phenolics and quinines in the isolation of plant enzymes and organelles. Methods Enzymol.16 528 544 - 95.
Blunden G. Roger D. J. Loveless R. W. Patel A. V. 1986 Haemagglutinins in marine algae: Lectins or Phenols? In: “Lectins: Biology, Biochemistry, Clin Biochem.5 139 145 - 96.
Calvete J. J. Costa F. H. F. Saker-Sampaio S. Moreno-Murciano M. P. Nagano C. S. BS Cavada Grangeiro. T. B. Ramos M. V. Bloch Jr C. Silveira S. B. Freitas B. T. Sampaio A. H. 2000 The amino acid sequence of the agglutinin isolated from the red marine alga Bryothamnion triquetrum defines a novel lectin structure. Cell Mol Lif Sci57 343 350 - 97.
Hori K. Matsubara K. Miyazawa K. 2000 Primary structures of two hemagglutinins from the red alga Hypnea japonica. Bioch Biophys Acta.1474 226 236 - 98.
Medina-Ramirez G. Gibbs R. V. Calvete J. J. 2006 Micro-heterogeneity and molecular assembly of the haemagglutinins from the red algae Bryothamnion seaforthii and B. triquetrum from the Caribbean Sea. Eur J Phycol.42 105 112 - 99.
Protein Sci.Nagano C. S. Debray H. Nascimento K. S. Pinto V. P. T. BS Cavada-Sampaio Saker. Farias S. Sampaio W. R. L. Calvete A. H. (200 J. J. H. C. A. isolated H. M. L. from the. red marine. algae Hypnea. cervicornis Hypnea musciformis. define a. novel lectin. family 14 2167 2176 - 100.
Kawabuko A. Makino H. Ohnishi J. Hirohara H. Hori K. 1999 Occurrence of highly yielded lectins homologous within the genus Eucheuma. J Appl Phycol.11 149 156 - 101.
Hori K. Sato Y. Ito K. Fujiwara Y. Iwamoto Y. Makino H. Kawakubo A. 2007 Strict specificity for high-mannose type N-glycans and primary structure of a red alga Eucheuma serra lectin. Glycobiology,17 479 9 - 102.
Mori T. O’Keefe B. R. Sowder I. I. R. C. Bringans S. Gardella R. Berg S. Cochran P. Turpin J. A. Buckheit Jr R. W. Mac Mahon. J. B. Boyd M. R. 2005 Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem,280 9345 9353 - 103.
Ishihara K. Arai S. Shimada S. 2009 cDNA cloning of a lectin-like gene preferentially expressed in freshwater from macroalga Ulva limnetica (ulcales, Chlorophyta). Phycol Res57 104 110 - 104.
Yoon KS, Lee KP, Klochkova TA, Kim GH 2008 Molecular characterization of the lectin, bryohealin, involved in protoplast regeneration of the marine alga Bryopsis plumosa (chlorophyta). J Phycol44 103 112 - 105.
Sato Y. Hirayama M. Morimoto K. Yamamoto N. Okuyama S. Hori K. 2011 High Mannose-binding Lectin with preference for the cluster of 1-2 Mannose from green Alga Boodlea coacta is potent inhibitor of HIV-1 and Influenza Viruses. J Biol Chem.286 19446 19458 - 106.
Sugahara T. Ohama Y. Fukuda A. Hayashi M. Kawakubo A. Kato K. 2001 The cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesicles. Cytotechnology.36 93 99 - 107.
Fukuda Y. Sugahara T. Ueno M. Fukuta Y. Ochi Y. Akiyama K. Miyazaki T. Masuda S. Kawakubo A. Kato K. 2006 The anti-tumor effect of Euchema serra agglutinin on colon cancer cells in vitro and in vivo. Anticancer Drugs.17 943 7 - 108.
Omokawa Y. Miyazaki T. Walde P. Akiyama K. Sugahara T. Masuda S. Inada A. Ohnishi Y. Saeki T. Kato K. 2010 In vitro and in vivo anti-tumor effects of novel Span 80 vesicles containing immobilized Eucheuma serra agglutinin. Int J Pharm.15 157 167 - 109.
Adv Pharmacol Sci. 2009: 862162.Pinto V. P. Debray H. Dus D. Teixeira E. H. de Oliveira T. M. Carneiro V. A. Teixeira A. H. Filho G. C. Nagano C. S. Nascimento K. S. Sampaio A. H. BS Cavada (200. Lectins from. the Red. Marine Algal. Species Bryothamnion. seaforthii Bryothamnion triquetrum. as Tools to. Differentiate Human. Colon Carcinoma. Cells - 110.
Bitencourt F. S. Figueiredo J. G. Mota M. R. Bezerra C. C. Silvestre P. P. Vale M. R. Nascimento K. S. Sampaio A. H. Nagano C. S. Saker-Sampaio S. Farias W. R. BS Cavada Assreuy. A. M. de Alencar N. M. 2008 Antinociceptive and anti-inflammatory effects of a mucin-binding agglutinin isolated from the red marine alga Hypnea cervicornis. Naunyn Schmiedebergs Arch Pharmacol.377 139 48 - 111.
Silva L. M. Lima V. Holanda M. L. Pinheiro P. G. Rodrigues J. A. ME Lima Benevides. N. M. 2010 Antinociceptive and anti-inflammatory activities of lectin from marine red alga Pterocladiella capillacea. Biol Pharm Bull.33 830 5 - 112.
Vanderlei E. S. Patoilo K. K. Lima N. A. Lima A. P. Rodrigues J. A. Silva L. M. ME Lima Lima. V. Benevides N. M. 2010 Antinociceptive and anti-inflammatory activities of lectin from the marine green alga Caulerpa cupressoides. Int Immunopharmacol.10 1113 8 - 113.
Hori K. Matsuda H. Miyazawa K. Ito K. 1987 A mitogenic agglutinin from the red alga Carpopeltis flabellate. Phytochemistry.26 1335 1338 - 114.
Liao W. R. Lin J. Y. Shieh W. Y. Jeng W. L. Huang R. 2003 Antibiotic activity of lectins from marine algae against marine vibrios. J Ind Microbiol Biotechnol.30 433 439 - 115.
Teixeira E. H. Napimoga M. H. Carneiro V. A. de Oliveira T. M. Nascimento K. S. Nagano C. S. Souza J. B. Havt A. Pinto V. P. Gonçalves R. B. Farias W. R. Saker-Sampaio S. Sampaio A. H. BS Cavada 2007 In vitro inhibition of oral streptococci binding to the acquired pellicle by algal lectins. J Appl Microbiol.103 1001 6 - 116.
Neves S. A. Dias-Baruff M. Freitas A. L. Roque-Barreira M. C. 2001 Neutrophil migration induced in vivo and in vitro by marine algal lectins. Inflamm Res.50 486 90 - 117.
Sato Y. Morimoto K. Hirayama M. Hori K. 2011 High mannose-specific lectin (KAA-2) from the red alga Kappaphycus alvarezii potently inhibits influenza virus infection in a strain-independent manner. Biochem Biophys Res Commun.405 291 6 - 118.
Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem.Mori T. O’Keefe B. R. Sowder R. C. 2nd Bringans. S. Gardella R. Berg S. Cochran P. Turpin J. A. Buckheit R. W. Jr Mc Mahon J. B. Boyd M. R. 280 9345 53 - 119.
Emau P. Tian B. O’keefe B. R. Mori T. Mc Mahon J. B. Palmer K. E. Jiang Y. Bekele G. Tsai C. C. 2007 Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide. J Med Primatol.36 244 53 - 120.
O’Keefe B. R. Giomarelli B. Barnard D. L. Shenoy S. R. Chan P. K. Mc Mahon J. B. Palmer K. E. Barnett B. W. Meyerholz D. K. Wohlford-Lenane C. L. Mc Cray P. B. Jr 2010 Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol.84 2511 21 - 121.
Abee T. Kovács A. T. Kuipers O. P. Van Der Veen S. 2010 Biofilm formation and dispersal in Gram-positive bacteria. Curr Opin Biotechnol.22 1 8 - 122.
Merritt J. Anderson M. H. Park N. H. Shi W. 2001 Bacterial biofilm and dentistry. J Calif Dent Assoc.29 355 60 - 123.
Donlan RM, Costerton JW 2002 Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev.15 167 193 - 124.
Graefes Arch Clin Exp Ophthalmol. Dez. 2010.Onurdağ F. K. Ozkan S. Ozgen S. Olmuş H. Abbasoğlu U. (201 Candida albicans. Pseudomonas aeruginosa. adhesion on. soft contact. lenses - 125.
Prosser B. T. Taylor P. A. Cix P. A. Cluland R. 1987 Method of evaluating effects of antibiotics on bacterial biofilms. Antimicrob. Agents Chemother.31 1502 1506 - 126.
Costerton J. W. Lewandowski Z. Caldwell D. E. Korber D. R. Lappin-Scott H. M. 1995 Microbial biofilms. Ann. Rev. Microbiol.49 711 745 - 127.
Mah TF, O’Toole GA 2001 Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol.9 1 34 39 - 128.
Costerton JW, Stewart PS, Greenberg EP 1999 Bacterial biofilms: A common cause of persistent infections. Scien.284 1318 1322 - 129.
Costerton W. Veeh R. Shirtliff M. Pasmore M. Post C. Ehrlich G. 2003 The application of biofilm science to the study and control of chronic bacterial infections. J. Clin. Invest.112 146 1477 - 130.
CA Fux Stoodley. P. Hall-Stoodley Costerton. J. W. 2003 Bacterial biofilms: a diagnostic and therapeutic challenge. Exp Rev Anti-infect Ther.1 4 667 683 - 131.
Alhede M. Bjarnsholt T. Jensen P. O. 2009 Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiol.155 3500 3508 - 132.
Van Gennip M. Christensen L. D. Alhede M. 2009 Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS.117 537 546 - 133.
Busscher H. J. Bos R. van der Mei H. C. 1995 Initial microbial adhesion is a determinant for the strength of biofilm adhesion. FEMS Microbiol. Lett.128 229 234 - 134.
Wu C. Mishra A. ME Reardon Huang. I. H. Counts S. C. Das A. Ton-That H. 2012 Structural determinants of Actinomyces sortase SrtC2 required for membrane localization and assembly of type 2 fimbriae for interbacterial coaggregation and oral biofilm formation. J Bacteriol. Mar 23. - 135.
Periasamy S. Kolenbrander P. E. 2010 Central role of the early colonizer Veillonella sp. in establishing multispecies biofilm communities with initial, middle, and late colonizers of enamel. J Bacteriol.192 12 2965 72 - 136.
Stoodley P. Sauer K. Davies D. G. Costerton J. W. 2002 Biofilms as complex differentiated communities. Annu Rev Microbiol.56 187 209 - 137.
Microbiol.Heydorn A. Ersboll B. K. Hentzer M. Parsek M. R. Givskov M. Molin S. (200 Experimental reproducibility. in flow-chamber. biofilms 146 2395 2407 - 138.
Xiao J. Klein M. I. Falsetta M. L. Lu B. Delahunty C. M. Yates J. R. 3rd Heydorn A. Koo H. 2012 The Exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm. PLoS Pathog. 8(4):e1002623 EOF - 139.
López D. Vlamakis H. Kolter R. 2010 Biofilms. Cold Spr Harb Perspect Biol. 2(7):a000398 EOF 85 EOF - 140.
Flemming HC, Neu TR, Wozniak DJ 2007 The EPS matrix: the "house of biofilm cells". J Bacteriol.189 22 7945 7 - 141.
Flemming H. C. Wingender J. 2010 The biofilm matrix. Nat Rev Microbiol.8 9 623 33 - 142.
EMBO J.Fronzes R. Remaut H. Waksman G. (200 Architectures biogenesis of. non-flagellar protein. appendages in. Gram-negative bacteria. E. M. B. 27 2271 80 - 143.
Dorkhan M. Chávez de Paz. L. E. Skepö M. Svensäter G. Davies J. 2012 Effects of saliva or serum coating on adherence of Streptococcus oralis strains to titanium. Microbiol.158 2 390 7 - 144.
Mukherjee J. Karunakaran E. CA Biggs 2012 Using a multi-faceted approach to determine the changes in bacterial cell surface properties influenced by a biofilm lifestyle. Biofouling.28 1 1 14 - 145.
Marsh PD 1994 Microbial ecology of dental plaque and its significance in health and disease. Adv. Dent. Res.8 263 271 - 146.
Nyvad B. 1993 Microbial colonization of human tooth surfaces. APMIS Suppl.32 1 45 - 147.
Thylstrup A. Fejerskov O. 1995 Cariologia clínica 2 ed. São Paulo: Santos, Cap. 3,45 49 - 148.
Ruhl S. Sandberg A. L. Cisar J. O. 2004 Salivary receptors for the proline-rich protein-binding and lectin-like adhesins of oral actinomyces and streptococci. J Dent Res.83 6 505 10 - 149.
Jenkinson HF, Lamont RJ 1997 Streptococcal adhesion and colonization. Crit Rev Oral Biol Med.8 2 175 200 - 150.
Korea G. K. Ghigo J. M. Beloin C. 2011 The sweet connection: Solving the riddle of multiple sugar-binding fimbrial adhesins in Escherichia coli: Multiple E. coli fimbriae form a versatile arsenal of sugar-binding lectins potentially involved in surface-colonisation and tissue tropism. Bioessays33 300 311 - 151.
Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer Jr RJ 2002 Communication among oral bacteria. Microbiol Mol Biol Rev.66 486 505 - 152.
Ferreira C. L. Grześkowiak L. Collado M. C. Salminen S. 2011 In vitro evaluation of Lactobacillus gasseri strains of infant origin on adhesion and aggregation of specific pathogens. J Food Prot.74 9 1482 7 - 153.
Okuda T. Okuda K. Kokubu E. Kawana T. Saito A. Ishihara K. 2012 Synergistic effect on biofilm formation between Fusobacterium nucleatum and Capnocytophaga ochracea. Anaerobe.18 1 157 61 - 154.
Handley PS, Rickard AH, High NJ, Leach SA 2001 Coaggregation- is it a universal phenomenon? In: Biofilm community interactions: Chance or Necessity (Gilbert, P., Allison, D., Verran, J., Brading, M. and Walker, J., Eds.),1 10 - 155.
Rodrigues D. F. Elimelech M. 2009 Role of type 1 fimbriae and mannose in the development of Escherichia coli K12 biofilm: from initial cell adhesion to biofilm formation. Biofoul.25 5 401 11 - 156.
Holmes AR, Gopal PK, Jenkinson HF ( Infect Immun.1995 ) Adherence of Candida albicans to a cell surface polysaccharide receptor on Streptococcus gordonii63 5 1827 34 - 157.
Rosen G. Sela M. N. 2006 Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide. FEMS Microbiol Lett.256 2 304 10 - 158.
Ryu JH, Beuchat LR 2005 Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl Environ Microbiol.71 1 247 54 - 159.
Simões L. C. Lemos M. Pereira A. M. Abreu A. C. MJ Saavedra Simões. M. 2011 Persister cells in a biofilm treated with a biocide. Biofoul.27 4 403 11 - 160.
Becer CR 2012 The glycopolymer code: Synthesis of glycopolymers and multivalent carbohydrate-lectin interactions. Macromol Rapid Commun. Apr 16. - 161.
Kurz K. Garimorth K. Joannidis M. Fuchs D. Petzer A. Weiss G. 2012 Altered immune responses during septicaemia in patients suffering from haematological malignancies. Int J Immunopathol Pharmacol.25 1 147 56 - 162.
Strathmann M. Wingender J. Flemming H. 2002 Application of fluorescently labelled lectins for the visualization and biochemical characterization of polysaccharides in biofilms of Pseudomonas aeruginosa. J. Microbiol. Methods50 237 248 - 163.
Wawrzynczyk J. Szewczyk E. Norrlöw O. Dey E. 2007 Application of enzymes, sodium tripolyphosphate and cation exchange resin for the release of extracellular polymeric substances from sewage sludge. Characterization of the extracted polysaccharides/glycoconjugates by a panel of lectins. J. Biotechnol.130 274 281 - 164.
Cavalcante TT, Rocha BAM, Carneiro VA, Arruda FVS, AS FN, Sá NC, Nascimento KS, Cavada BS, Teixeira EH 2011 Effect of lectins from Diocleinae subtribe against oral Streptococci. Molecul.16 5 3530 43 - 165.
Sanford BA; De Feijter AW, Wade MH, Thomas VL 1996 A dual fluorescence technique for visualization of Staphylococcus epidermidis biofilm using scanning confocal laser microscopy. J Ind Microbiol.16 1 48 56 - 166.
Thomas V. L. BA Sanford Moreno. R. MA Ramsay 1997 Enzyme-linked lectin sorbent assay measures N-acetyl-D-glucosamine in matrix of biofilm produced by Staphylococcus epidermidis. Curr Microbiol.35 4 249 54 - 167.
Mccoy Jr J. P. Varani J. Goldstein I. J. 1984 Enzyme-linked lectin assay (ELLA): Detection of carbohydrate groups on the surface of unfixed cells. Exper Cell Res.1 51 96 103 - 168.
Appl Environ Microbiol.Leriche V. Sibille P. Carpentier B. (200 Use of. an enzyme-linked. lectin sorbent. assay to. monitor the. shift in. polysaccharide composition. in bacterial. biofilms 66 5 1851 6 - 169.
Zippel B. Neu T. R. 2011 Characterization of glycoconjugates of extracellular polymeric substances in tufa-associated biofilms by using fluorescence lectin-binding analysis. Appl Environm Microbiol.77 505 516 - 170.
Rebiere-Huët J. Di Martino P. Hulen C. 2004 Inhibition of Pseudomonas aeruginosa adhesion to fibronectin by PA-IL and monosaccharides: involvement of a lectin-like process. Can J Microbiol.50 5 303 12 - 171.
Teixeira E. H. Napimoga M. H. Carneiro V. A. de Oliveira T. M. Cunha R. M. Havt A. Martins J. L. Pinto V. P. Gonçalves R. B. BS Cavada 2006 In vitro inhibition of Streptococci binding to enamel acquired pellicle by plant lectins. J Appl Microbiol.101 1 111 6 - 172.
Islam B. Khan S. N. Naeem A. Sharma V. Khan A. U. 2009 Novel effect of plant lectins on the inhibition of Streptococcus mutans biofilm formation on saliva-coated surface. J Appl Microbiol.106 5 1682 9